AI Article Synopsis
- The study investigates the rare occurrence of colorectal cancer (CRC) in patients with Crohn's disease (CD), focusing on clinicopathological characteristics and treatment outcomes.
- A total of 823 patients with CD who underwent abdominal surgery were analyzed, with only 19 (2.3%) developing CD-related CRC, predominantly adenocarcinomas.
- Results indicate that longer durations of CD and colonic location are significant risk factors for developing CRC, with rectal adenocarcinoma representing the majority of cases.
Article Abstract
Purpose: Carcinoma arising from Crohn disease (CD) is rare, and there is no clear guidance on how to properly screen for at-risk patients and choose appropriate care. This study aimed to evaluate the clinicopathological characteristics, treatment, and oncologic outcomes of CD patients diagnosed with colorectal cancer (CRC).
Methods: Using medical records, we retrospectively enrolled a single-center cohort of 823 patients who underwent abdominal surgery for CD between January 2006 and December 2015. CD-associated CRC patients included those with adenocarcinoma, lymphoma, or neuroendocrine tumors of the colon and rectum.
Results: Nineteen patients (2.3%) underwent abdominal surgery to treat CD-associated CRC. The mean duration of CD in the CD-associated CRC group was significantly longer than that in the benign CD group (124.7 ± 77.7 months vs. 68.9 ± 60.2 months, P = 0.006). The CD-associated CRC group included a higher proportion of patients with a history of perianal disease (73.7% vs. 50.2%, P = 0.035) and colonic location (47.4% vs. 6.5%, P = 0.001). Among 19 CD-associated CRC patients, 17 (89.5%) were diagnosed with adenocarcinoma, and of the 17 cases, 15 (88.2%) were rectal adenocarcinoma. On multivariable analyses for developing CRC, only colonic location was a risk factor (relative risk, 7.735; 95% confidence interval, 2.862-20.903; P = 0.001).
Conclusion: Colorectal malignancy is rare among CD patients, even among patients who undergo abdominal surgery. Rectal adenocarcinoma accounted for most of the CRC, and colonic location was a risk factor for developing CRC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134931 | PMC |
| http://dx.doi.org/10.3393/ac.2020.11.02 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Colorectal cancer and inflammatory bowel diseases share common salivary proteomic pathways.
Sci Rep
July 2024
Department of Medicine (DIMED), University of Padova, 35128, Padova, Italy.
Inflammatory bowels diseases (IBD) are high risk conditions for colorectal cancer (CRC). The discovery of IBD and CRC noninvasive protein/peptide biomarkers using saliva and feces was the aim of this study involving 20 controls, 25 IBD (12 Crohn's Disease-CD), 37 CRC. By untargeted proteomic (LTQ-Orbitrap/MS), a total of 152 proteins were identified in saliva.
View Article and Find Full Text PDFCrohn's Disease-Associated Anorectal Cancer Has a Poor Prognosis With High Local Recurrence: A Subanalysis of the Nationwide Japanese Study.
Am J Gastroenterol
September 2023
Tokyo Medical and Dental University, Tokyo, Japan.
Article Synopsis
- Colorectal cancer (CRC) presents a significant risk for patients with Crohn's disease (CD), and this study aimed to investigate the prognosis and characteristics of CD-related CRC (CD-CRC) compared to sporadic CRC using a large database of cases.
- The analysis included 233 CD-CRC patients and 129,783 sporadic CRC patients, revealing that CD-CRC patients were typically younger, more likely to have rectal cancer, multiple tumors, and a distinct type of cancer called mucinous adenocarcinoma, all resulting in lower survival rates.
- The findings showed a lower five-year overall survival rate for CD-CRC (53.99% vs. 71.17% for sporadic CRC
Clinicopathological Characteristics and Surgical Outcomes of Crohn Disease-Associated Colorectal Malignancy.
Ann Coloproctol
April 2021
Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Article Synopsis
- The study investigates the rare occurrence of colorectal cancer (CRC) in patients with Crohn's disease (CD), focusing on clinicopathological characteristics and treatment outcomes.
- A total of 823 patients with CD who underwent abdominal surgery were analyzed, with only 19 (2.3%) developing CD-related CRC, predominantly adenocarcinomas.
- Results indicate that longer durations of CD and colonic location are significant risk factors for developing CRC, with rectal adenocarcinoma representing the majority of cases.
Similarities and differences in clinical and pathologic features of inflammatory bowel disease-associated colorectal cancer in China and Canada.
Chin Med J (Engl)
November 2019
Department of Pathology and Laboratory Medicine, University of Calgary Cummings School of Medicine, and Calgary Laboratory Services, Calgary, Canada.
Article Synopsis
- - The study investigates colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD) in China and Canada, comparing clinical and pathological characteristics from 78 patients over 13 years.
- - Results show that the Beijing group had a higher percentage of ulcerative colitis (UC), younger average age at CRC diagnosis, and fewer mucinous adenocarcinomas compared to the Calgary group.
- - Despite these differences, both groups exhibited similar features of IBD-CRC such as prolonged colitis duration, active inflammation, and advanced cancer stages, highlighting some shared risks and characteristics between populations.
[Crohn's disease-associated colorectal carcinogenesis : TP53 mutations and copy number gains of chromosome arm 5p as (early) markers of tumor progression].
Pathologe
December 2018
Institut für Pathologie, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland.
Background: Patients with inflammatory bowel diseases, i. e., ulcerative colitis and Crohn's disease (CD), face an increased risk of developing colorectal cancer (CRC).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!